Last reviewed · How we verify
POLIOVIRUS VACCINE INACTIVATED
POLIOVIRUS VACCINE INACTIVATED is a drug. It is currently FDA-approved.
Poliovirus Vaccine Inactivated is a marketed vaccine with a key composition patent expiring in 2028. The vaccine holds a strong position due to its established efficacy and safety profile in preventing polio. The primary risk is the potential increase in competition post-patent expiry in 2028.
At a glance
| Generic name | POLIOVIRUS VACCINE INACTIVATED |
|---|---|
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Phase IV Clinical Study of Sequential Vaccination of Sabin Strain and Wild Strain Inactivated Poliovirus Vaccine (PHASE4)
- BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies (PHASE3)
- A Study on the Immune Response and Safety of a Multicomponent Shigella Vaccine in Preventing Shigellosis in Infants (PHASE2)
- Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Given With Routine Pediatric Vaccines in Healthy Infants and Toddlers in India and the Republic of South Africa (PHASE3)
- Phase IV Clinical Study of sIPV Administration in Adolescent and Adult Populations (PHASE4)
- Immunogenicity of 2 Versus 3 Doses of Combined Hepatitis B Vaccines in 2-18 Months Old Children (PHASE4)
- Safety and Immunogenicity of an Investigational Pentavalent Meningococcal ABCYW Vaccine Against Meningococcal Disease in Children, Toddlers, and Infants (PHASE1, PHASE2)
- the Five-year Antibody Persistence After Immunization With IPV, MMR and HepA-L Vaccines
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- POLIOVIRUS VACCINE INACTIVATED CI brief — competitive landscape report
- POLIOVIRUS VACCINE INACTIVATED updates RSS · CI watch RSS
Frequently asked questions about POLIOVIRUS VACCINE INACTIVATED
What is POLIOVIRUS VACCINE INACTIVATED?
POLIOVIRUS VACCINE INACTIVATED is a pharmaceutical drug.
What development phase is POLIOVIRUS VACCINE INACTIVATED in?
POLIOVIRUS VACCINE INACTIVATED is FDA-approved (marketed).